Joachim G.J.V. Aerts

University of Groningen — Netherlands

Medicine · Health Sciences

69h-index30.1kcitations656works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(218), Lung Cancer Treatments and Mutations(153), Immunotherapy and Immune Responses(133), Lung Cancer Research Studies(104), Occupational and environmental lung diseases(89)

Publications650 total

Adherence to Inhaled Medication Guidelines in Patients with COPD: Evaluating the GOLD 2023 Strategy in a Real-World Secondary Care Setting
International Journal of COPD·2025· 2 citedOpen Access
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
Nature Communications·2025· 1 citedOpen Access
Trajectories of device-assessed physical activity and sleep in ICU- and non-ICU-treated patients up to 2 years after hospitalization for COVID-19, and their association with health-related quality of life
Quality of Life Research·2025Open Access
Shared decision-making in the treatment of non-small cell lung cancer stage I–IV: perspectives from patients and clinicians
BMJ Open Respiratory Research·2025Open Access
Progress in outcomes for patients with metastatic squamous non-small-cell lung cancer
The Lancet·2025
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
Lung Cancer·2025Open Access
P1.17.54 Long-Term Outcomes From Pembrolizumab in Patients With Advanced PD-L1 =50% NSCLC and Poor PS: A Transformer-Based AI Approach
Journal of Thoracic Oncology·2025
EP.13.15 Outcome and Safety of Lurbinectedin as Compassionate Use in SCLC: A Retrospective Multicentric International Study
Journal of Thoracic Oncology·2025
Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors or Blocking Antibodies? Unraveling Vascular Endothelial Growth Factor Inhibition Strategies
Journal of Thoracic Oncology·2025Open Access
OA01.01 Genetic and Air Pollution Scores Identify Individuals at Elevated Risk in a Lung Cancer Screening Cohort
Journal of Thoracic Oncology·2025
2218P REACtiVe-2: Phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
Annals of Oncology·2025Open Access
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry
Journal for ImmunoTherapy of Cancer·2025· 1 citedOpen Access
External Test of a Deep Learning Algorithm for Pulmonary Nodule Malignancy Risk Stratification Using European Screening Data
Radiology·2025· 4 cited
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials
Nature Communications·2025Open Access
An optimal transport-based low-dimensional visualization framework for high-parameter flow cytometry
2025Open Access
[Financial toxicity in cancer patients].
PubMed·2025
Outcome and safety of lurbinectedin as compassionate use in extensive stage small cell lung cancer: A multicentric international cohort
European Journal of Cancer·2025· 1 citedOpen Access
Long-term multidimensional patient-centred outcomes after hospitalisation for COVID-19: do not only focus on disease severity
BMJ Open Respiratory Research·2025· 1 citedOpen Access
Efficacy and safety of nivolumab plus ipilimumab for patients with pre-treated type B3 thymoma and thymic carcinoma: Results from the EORTC-ETOP NIVOTHYM phase II trial.
Journal of Clinical Oncology·2025· 2 cited
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study
Nature Communications·2025· 7 citedOpen Access
page 1 of 33Next →

Frequent Co-authors

Joost P. Hegmans(11), Henk C. Hoogsteden(10), Rudi W. Hendriks(9), Harry J.M. Groen(5), Menno van Nimwegen(5), Jan P. van Meerbeeck(5), Paul Baas(4), Floris Dammeijer(4), Arnaud Scherpereel(4), Koen Bezemer(4), Luca Cantini(4), Robin Cornelissen(4), Libor Havel(3), Marina Chiara Garassino(3), Martin Reck(3), Kristiaan Nackaerts(3), Thorbald van Hall(3), S. Cedrés(3), Dean A. Fennell(3), Fabrice Barlési(3)